[{"Assets_0_Q2_USD":"10074289000.0","CIK":"1593034","CommonStockSharesConverted_0_Q2_shares":"226391081.0","CommonStockSharesOutstanding_0_Q2_shares":"226391081.0","Country":"Ireland","EarningsPerShareBasic_1_Q2_USD":"-0.47","EarningsPerShareBasic_2_Q2_USD":"-0.55","EarningsPerShareDiluted_1_Q2_USD":"-0.47","EarningsPerShareDiluted_2_Q2_USD":"-0.55","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","Market Cap":"640358301.0","NetCashProvidedByUsedInOperatingActivitiesConverted_2_Q2_USD":"86602000.0","NetIncomeLossConverted_1_Q2_USD":"-106005000.0","NetIncomeLossConverted_2_Q2_USD":"-124578000.0","OfficialName":"Endo International plc Ordinary Shares","RevenuesConverted_1_Q2_USD":"699727000.0","RevenuesConverted_2_Q2_USD":"1420138000.0","SP500":null,"Sector":"Health Care","StockholdersEquity_0_Q2_USD":"-590472000.0","Ticker":"ENDP","WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":"226221000.0","WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":"225408000.0","WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":"226221000.0","WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":"225408000.0","filed":"20190805","footnote":null,"form":"10-Q","fp":"Q2","fy":"2019.0","name":"ENDO INTERNATIONAL PLC","period":"20190630","qtrs":"0","uom":"USD"}]